https://www.cochrane.org/ms/evidence/CD010961_perampanel-add-drug-resistant-focal-epilepsy
Tambahan perampanel untuk epilepsi fokal yang tahan ubat | Cochrane
tambahanperampaneluntukepilepsifokal
https://adisinsight.springer.com/drugsafety/803727752?error=cookies_not_supported&code=ca7b8ef4-4a60-40b5-98e3-708954100a9b
Levetiracetam/perampanel/topiramate - AdisInsight
In a study of 62 patients, a 30-year-old man and a 9-year-old girl were described, who developed hostile behaviour (n=1) and aggression and irritability (n=1)
levetiracetamperampaneltopiramateadisinsight
https://adisinsight.springer.com/drugsafety/803856749?error=cookies_not_supported&code=431fca5b-f3c0-4cf6-b528-ff272ff9efe0
Lacosamide/perampanel - AdisInsight
A 41-year-old woman exhibited lack of efficacy during treatment with lacosamide and perampanel for complex partial seizures [dosages and routes not stated].The
lacosamideperampaneladisinsight
https://adisinsight.springer.com/patents/800015670
Perampanel - Eisai - AdisInsight
perampaneleisaiadisinsight
https://www.fycompa.com/
FYCOMPA® (perampanel) CIII: Treatment for Partial-Onset (4 yrs+) & PGTC (12 yrs+) Seizures
treatment for
https://adisinsight.springer.com/drugsafety/803675800?error=cookies_not_supported&code=a68ea34f-92ea-445d-ad22-12a515a3f3f8
Perampanel - AdisInsight
In a multicenter, noninterventional, retrospective, phase IV study (NCT03208660) of 1121 patients conducted between 10 April 2017 01 April 2019, one patient
perampaneladisinsight